课题基金 / 基金详情

项目摘要

项目成果

PETER KUHN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The signaling cascades of the Eph receptor tyrosine kinase family and the ephrin ligands have been implicated in pathological forms of angiogenesis and tumorigenesis. While initial invesfigations have focused on the role of this protein-protein interaction in axonal guidance, cell attachment and motility, there is now signiflcant evidence forthe overexpression and dysregulation of this interaction in numerous cancerous tissues. The key research hypothesis of this proposal is that a limited set of structural determinants are responsible for the promiscuity and selectivity of ligand recognifion exhibited by the Eph receptor family, and that these structural determinants can be exploited for small molecule modulators of this interaction. The proposed research will result in a demonstrated descripfion and characterizafion of the mode of binding across this large family of receptor-ligand interactions. The outcome will be translated in a discovery approach to the development of small molecule compounds that exploit these structural determinants. Aim 1: Evaluate structural determinants of specificity versus promiscuity in Eph receptor-ligand binding by using X-ray crystallography. Aim 2: Develop strategies to stabilize the flexible Eph receptor J-K loop in the ephrin-binding cleft to facilitate receptor crystallization in complex with small molecular weight chemical compounds. Aim 3: Characterize and improve small molecular weight chemical compounds identified in high throughput screens and virtual ligand screens for inhibitors of EphB2 and EphB4 receptor ligand binding.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma
Clinical validation of the HD-CTC fluid biopsy in early detection of lung cancer.
  • 批准号:
    8625205
  • 项目类别:
  • 资助金额:
    $47.63万
  • 财政年份:
    2013
  • 负责人:
    PETER KUHN
  • 依托单位:
Clinical validation of the HD-CTC fluid biopsy in early detection of lung cancer.
  • 批准号:
    8738620
  • 项目类别:
  • 资助金额:
    $52.11万
  • 财政年份:
    2013
  • 负责人:
    PETER KUHN
  • 依托单位:
Administration
  • 批准号:
    8726302
  • 项目类别:
  • 资助金额:
    $6.44万
  • 财政年份:
    2013
  • 负责人:
    PETER KUHN
  • 依托单位:
海外基金